Atlas Trials

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

Clinical trial NCT03240939 · COMPLETED

Trial details

NCT number
NCT03240939
Sponsor
Yuyu Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Benign Prostatic Hyperplasia
Start date
2017-03-27
Primary completion
2017-07-07
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.